We previously studied the effect of three genetic markers in the CES1 gene (rs2244613 and rs71647871 and the variant with a weak promoter, CES1A1c) on the pharmacokinetics of enalapril in patients with arterial hypertension [12]. This evidence concerns the gene CES1 and Hypertension.